Asciminib

TypeName: Business Offer
Category:
Offer Date:2019/09/04
Country: United States
Summary: Asciminib, also known as ABL-001, is a potent and selective allosteric Bcr-Abl inhibitor. Asciminib inhibits Ba/F3 cell growth with an IC50 of 0.25 nM. https://www.bocsci.com/asciminib-cas-1492952-76-7-item-7699.html
Description:
OfferId: 5447
Name:Alex Brown
Telphone:
Categories